参考文献/References:
[1] Fabre A, Sheppard MN. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death[J].Heart,2006,92(3):316-320.
[2] Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians[J].Med J Aust,2004,180(3):110-112.
[3] Puranik R, Chow CK, Duflou JA, et al. Sudden death in the young[J].Heart Rhythm,2005,2(12):1277-1282.
[4] Virmani R, Burke AP, Farb A. Sudden cardiac death[J].Cardiovasc Pathol,2001,10(6):275-282.
[5] Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy[J].Am Heart J,2000,140(5):785-791.
[6] Kallianos K, Moraes GL, Ordovas KG. Prognostic role of MR imaging in nonischemic myocardial disease[J].Magn Reson Imaging Clin N Am,2015,23(1):89-94.
[7] Rost C, Rost MC, Breithardt OA, et al. Relation of functional echocardiographic parameters to infarct scar transmurality by magnetic resonance imaging[J].J Am Soc Echocardiogr,2014,27(7):767-774.
[8] Emrich T, Emrich K, Abegunewardene N, et al. Cardiac magnetic resonance enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers, and unobstructed coronary arteries[J].Br J Radiol,2015,88(1049):20150025.
[9] Gahide G, Bertrand D, Roubille F, et al. MR delayed enhancement imaging findings in suspected acute myocarditis[J].Eur Radiol,2010,20(1):65-72.
[10] Natale L, de Vita A, Baldari C, et al. Correlation between clinical presentation and delayed-enhancement MRI pattern in myocarditis[J].Radiol Med,2012,117(8):1309-1319.
[11] Dill T, Ekinci O, Hansel J, et al. Delayed contrast-enhanced magnetic resonance imaging for the detection of autoimmune myocarditis and long-term follow-up[J].J Cardiovasc Magn Reson,2005,7(2):521-523.
[12] Bhatia M. Myocarditis: non invasive imaging of myocardial muscle in ventricular tachycardia by cardiac MRI[J].Indian Heart J,2014,66(6):731-732.
[13] Jaarsma C, Schalla S, Cheriex EC, et al. Incremental value of cardiovascular magnetic resonance over echocardiography in the detection of acute and chronic myocardial infarction[J].J Cardiovasc Magn Reson,2013,15:5.
[14] Liang JJ, Hebl VB, DeSimone CV, et al. Electrogram guidance:a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis[J].JACC Heart Fail,2014,2(5):466-473.
[15] Zhang J, He S, Qi X, et al. Combined electrocardiography, coronary angiography and magnetic resonance imaging for the diagnosis of viral myocarditis:a case report[J].Exp Ther Med,2014,7(6):1643-1646.
[16] 杨明,冯彦林,冼伟均,等. 201Tl心肌显像诊断病毒性心肌炎[J].中国医学影像技术,2010,26(9):1759-1761.
[17] di Bella G, Florian A, Oreto L, et al. Electrocardiographic findings and myocardial damage in acute myocarditis detected by cardiac magnetic resonance[J].Clin Res Cardiol,2012,101(8):617-624.
[18] 陈冰华,钟玉敏. MR延迟增强扫描在心肌炎诊断及预后评估中的应用进展[J].国际医学放射学杂志,2014,37(6):536-540.
[19] Stensaeth KH, Hoffmann P, Fossum E, et al. Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis[J].Int J Cardiovasc Imaging,2012,28(2):327-335.
[20] Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies[J].Eur Heart J,2005,26(15):1461-1474.
[21] Moraes GL, Higgins CB, Ordovas KG. Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease[J].J Thorac Imaging,2013,28(2):84-92.
[22] Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association[J].Circulation,2002,105(4):539-542.
[23] Nucifora G, Miani D, di Chiara A, et al. Infarct-like acute myocarditis:relation between electrocardiographic findings and myocardial damage as assessed by cardiac magnetic resonance imaging[J].Clin Cardiol,2013,36(3):146-152.
[24] Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis:comparison of different approaches[J].J Am Coll Cardiol,2005,45(11):1815-1822.
[25] Kromen W, Korkusuz H, Korkusuz Y, et al. Correlation of left ventricular wall thickness, heart mass,serological parameters and late gadolinium enhancement in cardiovascular magnetic resonance imaging of myocardial inflammation in an experimental animal model of autoimmune myocarditis[J].Int J Cardiovasc Imaging,2012,28(8):1983-1997.
[26] Nassenstein K, Breuckmann F, Bucher C, et al. How much myocardial damage is necessary to enable detection of focal late gadolinium enhancement at cardiac MR imaging?[J].Radiology,2008,249(3):829-835.
相似文献/References:
[1]陈文浩 张焕基 郭攸胜 张东辉.活检证实病毒性心肌炎的治疗策略及预后[J].心血管病学进展,2019,(5):813.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.037]
Chen WenhaoZhang HuanjiGuo YoushengZhang Donghui.Treatment Strategy and Prognosis of Viral Myocarditis Confirmed by Biopsy[J].Advances in Cardiovascular Diseases,2019,(5):813.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.037]
[2]陈丰 苏强 朱继金.高迁移率族蛋白B1在心脏炎症反应性疾病中的研究进展[J].心血管病学进展,2019,(8):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
CHEN Feng,SU Qiang,ZHU Jijin.Research Progress of HMGB1 in Myocardial Inflammatory Reactivity Disease[J].Advances in Cardiovascular Diseases,2019,(5):1111.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.010]
[3]张艺文 蔡琳 秦莉 杨晓倩 汪汉.基于网络药理学的参麦注射液治疗新型冠状病毒感染合并心肌炎的机制研究[J].心血管病学进展,2020,(10):1101.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.024]
ZHANG YiwenCAI LinQIN LiYANG XiaoqianWANG Han.Shenmai Injection for COVID-19 with Myocarditis Based on Network Pharmacology[J].Advances in Cardiovascular Diseases,2020,(5):1101.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.024]
[4]王斯 魏欣 肖乾凤 陈晓平.心肌炎的分类及治疗进展[J].心血管病学进展,2021,(4):337.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.012]
WANG Si,WEI Xin,XIAO Qianfeng,et al.The Classification and Treatment Progress of Myocarditis[J].Advances in Cardiovascular Diseases,2021,(5):337.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.012]
[5]杨晓倩 秦莉 张艺文 汪汉.苦参治疗新型冠状病毒感染合并心肌炎的网络药理学分析[J].心血管病学进展,2021,(6):566.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.021]
YANG Xiaoqian,QIN Li,ZHANG Yiwen,et al.Network Pharmacological Analysis of Sophora Flavescens on Novel Coronavirus Infection complicated with Myocarditis[J].Advances in Cardiovascular Diseases,2021,(5):566.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.021]
[6]肖乾凤 王斯 刘燕扬 魏欣.免疫检查点抑制剂相关性心肌炎的诊治[J].心血管病学进展,2022,(7):610.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
Inhibitors-Related Myocarditis.Diagnosis and Treatment of Immune Checkpoint[J].Advances in Cardiovascular Diseases,2022,(5):610.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[7]代虎威 王馨焱 李松珊 温泽宇 曾康 杨滨.免疫检查点抑制剂相关心肌炎的诊断及管理研究进展[J].心血管病学进展,2022,(10):937.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.017]
Immune Checkpoint Inhibitor-Associated Myocarditis.Diagnosis and Management of[J].Advances in Cardiovascular Diseases,2022,(5):937.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.017]
[8]朱煜欣 王天博 刘晓翰 张悦 何韵 黄刚 徐俊波.炎症性心肌病的机制及治疗进展[J].心血管病学进展,2024,(4):317.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.007]
ZHU Yuxin,WANG Tianbo,LIU Xiaohan,et al.Advances in the Pathogenesis and Treatment of Inflammatory Cardiomyopathy[J].Advances in Cardiovascular Diseases,2024,(5):317.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.007]